VAERS Explorer
Back to explore

Report #2846484

Received Jun 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Jun 6, 2025
Onset
Jun 8, 2025
Days to onset
2
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (1)

Rash

Symptom narrative

Rash on torso and arms; This non-serious case was reported by a consumer and described the occurrence of rash in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 06-JUN-2025, the patient received the 1st dose of Shingrix. On 08-JUN-2025, 2 days after receiving Shingrix, the patient experienced rash (Verbatim: Rash on torso and arms). The outcome of the rash was not resolved. It was unknown if the reporter considered the rash to be related to Shingrix. It was unknown if the company considered the rash to be related to Shingrix. Additional Information: GSK Receipt Date: 08-JUN-2025 The patient had rash on torso and arms. It was reported that online review stated that rash is a rare situation with this vaccine, was not rare for the patient.